RSS  JOBS   SITE MAP 
 HOME 
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
 RESOURCE CENTER 
 SUBSCRIBE 
 SUBSCRIBE ASIA DIGEST 
  Friday, September 3, 2010 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

Pharma Companies In India
BIO INDIA
"ICMR provides encouraging leads for product development"
Rahul Koul
In an exclusive interview with BioSpectrum, Dr Vishwa Mohan Katoch, director general, Indian Council of Medical Research and secretary, Department of Health Research, shares his views on key operations and priorities of ICMR and a host of issues.
Shortage of reagents to drive Indian IVD market growth
According to healthcare market research publisher Kalorama Information, IVD market in India is expected to enjoy a 15 percent growth rate through 2014
TODAY'S NEWS
  Scientists discover protein that fuels Alzheimer's disease
  Agensys initiates phase I of renal cancer drug
  Pfizer to acquire drug developer FoldRx
  Varian establishes radiotherapy training center in India
  Yongye enters into $59 mn revolving credit facilities
  Ono licenses Concordia's cancer drug in Japan
Advertisement
 
Digital Mag

Issue: July, 2010
Current Issue
View / Download
Top Story
Are biofuels poised for a leap?
 
 
 
Print Edition
Issue: Aug 2010
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement



















 

NEWS
CARD develops innovative therapy for Multiple Sclerosis
Centre For Advanced Research and Development (CARD), of Scalene Cybernetics, a leader in innovative medical technologies is all set to make a pioneering contribution to the world of medicine for the treatment of Multiple Sclerosis
Sun Pharma's NJ unit receives warning from FDA
US Food and Drug Administration has warned the US unit of Indian drugmaker Sun Pharmaceutical for violations of current good manufacturing practice at a plant in New Jersey.
FEATURES
2012 not the end of world for pharma: IMS Health
The new study by IMS Health predicts that the period between 2015- 2020 will see accelerated growth with pharma companies breaking away from the traditional strategy of replying to a few blockbusters
"ICMR provides encouraging leads for product development"
In an exclusive interview with BioSpectrum, Dr Vishwa Mohan Katoch, director general, Indian Council of Medical Research and secretary, Department of Health Research, shares his views on key operations and priorities of ICMR and a host of issues.
PEOPLE
Dr McCullough to lead PPD's Quality Management Systems
PPD has named Dr Neil McCullough as vice president of its quality management systems. He will provide strategic direction for quality management across all lines of business and ensure full compliance with global regulations
Sudhir Kant joins Avesthagen
Mr Kant was earlier heading the Indian operations of Millipore India, a wholly-owned subsidiary of the Millipore Group
EVENTS
LCRA launches BioQuizitive 2010 in India
Lotus Clinical Research Academy (LCRA) has launched BioQuizitive 2010 The national level life sciences quiz. BioQuizitive is India's first national-level quiz competition in the life sciences space and is open only for life science professionals
CII's Life Science conclave at Delhi
To provide a forum to present and discuss the role of key towards realizing Indias potential in R&D and making it a hub of Pharma and Biotech Innovation, The Confederation of Indian Industry (CII), is organizing a two day Life Science Conclave fro
R & D
Glenmark discovers novel chemical entity for pain, respiratory disorders
Glenmark has discovered a Novel Chemical Entity 'GRC 17536', a TRPA1 receptor antagonist, a potential first-in-class molecule globally
Indo-Japanese study: Daily Intake of 'Yakult' reduces diarrhea in children
Japan's Yakult Honsha, announced that its joint study with India on the incidence of acute diarrhea showed that daily intake of "Yakult" is efficacious in reducing the incidence of diarrhea in young children
POLICIES
Sun Pharma gets USFDA approval for Venlafaxine
Sun Pharma, India announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets.
GEAC permits 3 more GM crop trials
The Genetic Engineering Appraisal Committee (GEAC) which met on July 30 in Hyderabad, has given the go ahead to agribiotech companies for the field trials of 3 more GM crops. India
PRODUCTS
Sun Pharma's generic Strattera capsules gets FDA nod
Sun Pharma's subsidiary gets FDA approval to market a generic version of Strattera, atomoxetine hydrochloride capsules
AIIMS first to launch O-arm for spinal surgery in SE Asia
The technology by US based Medtronic Inc, offers highest degree of accuracy for the spine procedure
TRENDS & ANALYSIS
Indian Biotech Industry to be $ 8 bn by 2015: CII-Yes Bank Knowledge Report
The recently released Confederation of Indian Industries (CII)- Yes bank knowledge report on the Life Sciences Industry has estimated that the Indian Biotechnology Industry would grow at a CAGR of 20% to achieve a market size of $ 8 billion by 2015
Shortage of reagents to drive Indian IVD market growth
According to healthcare market research publisher Kalorama Information, IVD market in India is expected to enjoy a 15 percent growth rate through 2014
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black